10 Best Immunology Stocks To Buy Now

5. Twist Bioscience Corporation (NASDAQ:TWST)

Number of Hedge Fund Holders: 26

Twist Bioscience Corporation (NASDAQ:TWST) is a synthetic biology company that revolutionizes DNA synthesis by using silicon chips instead of traditional plastic plates, enabling more efficient and cost-effective production. Its product portfolio includes synthetic genes, gene fragments, oligonucleotides, NGS tools, and antibody discovery solutions, supporting applications in drug development, disease treatment, sustainable agriculture, and DNA-based data storage.

Twist Bioscience Corporation (NASDAQ:TWST), standing fifth in our list of best immunology stocks to buy now,  is advancing immunology through its innovative DNA synthesis technology and antibody discovery platforms. The company is developing a proprietary “Library of Libraries” to rapidly identify antibodies for immunological targets and has partnered with Kyowa Kirin to explore antibodies targeting G-protein coupled receptors (GPCRs), which regulate immune system function. Additionally, the corporation is working on checkpoint inhibitor research, including its TB206-001 antibody, which could enhance cancer immunotherapy.

In tumor microenvironment research, Twist Bioscience Corporation (NASDAQ:TWST) collaborates with Astellas Pharma to identify antibodies that reduce immunosuppression in tumors, aiming to boost anti-tumor immunity. The company also integrates AI and machine learning into antibody discovery and offers high-throughput antibody production for faster therapeutic development. It is targeting challenging immune system proteins, such as GPCRs and ADORA2A, and has formed partnerships with organizations like MediSix Therapeutics and Pure Biologics to further immunology research.